COMPAR-EU Recommendations on Self-Management Interventions in Type 2 Diabetes Mellitus.

GRADE approach diabetes mellitus recommendations self-management interventions type 2

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
16 Feb 2024
Historique:
received: 25 10 2023
revised: 24 01 2024
accepted: 04 02 2024
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 23 2 2024
Statut: epublish

Résumé

Self-management interventions (SMIs) offer a promising approach to actively engage patients in the management of their chronic diseases. Within the scope of the COMPAR-EU project, our goal is to provide evidence-based recommendations for the utilisation and implementation of SMIs in the care of adult individuals with type 2 diabetes mellitus (T2DM). A multidisciplinary panel of experts, utilising a core outcome set (COS), identified critical outcomes and established effect thresholds for each outcome. The panel formulated recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach, a transparent and rigorous framework for developing and presenting the best available evidence for the formulation of recommendations. All recommendations are based on systematic reviews (SR) of the effects and of values and preferences, a contextual analysis, and a cost-effectiveness analysis. The COMPAR-EU panel is in favour of using SMIs rather than usual care (UC) alone (conditional, very low certainty of the evidence). Furthermore, the panel specifically is in favour of using ten selected SMIs, rather than UC alone (conditional, low certainty of the evidence), mostly encompassing education, self-monitoring, and behavioural techniques. The panel acknowledges that, for most SMIs, moderate resource requirements exist, and cost-effectiveness analyses do not distinctly favour either the SMI or UC. Additionally, it recognises that SMIs are likely to enhance equity, deeming them acceptable and feasible for implementation.

Identifiants

pubmed: 38391858
pii: healthcare12040483
doi: 10.3390/healthcare12040483
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union
ID : Nº 754936

Auteurs

Jessica Beltran (J)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Claudia Valli (C)

Avedis DonabedianResearch Institute (FAD), Universitat Autònoma de Barcelona, 008037 Barcelona, Spain.

Melixa Medina-Aedo (M)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Carlos Canelo-Aybar (C)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Ena Niño de Guzmán (E)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Yang Song (Y)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.

Carola Orrego (C)

Avedis DonabedianResearch Institute (FAD), Universitat Autònoma de Barcelona, 008037 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 08007 Barcelona, Spain.

Marta Ballester (M)

Avedis DonabedianResearch Institute (FAD), Universitat Autònoma de Barcelona, 008037 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 08007 Barcelona, Spain.

Rosa Suñol (R)

Avedis DonabedianResearch Institute (FAD), Universitat Autònoma de Barcelona, 008037 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 08007 Barcelona, Spain.

Janneke Noordman (J)

Netherlands Institute for Health Services Research (NIVEL), 3513 CR Utrecht, The Netherlands.

Monique Heijmans (M)

Netherlands Institute for Health Services Research (NIVEL), 3513 CR Utrecht, The Netherlands.

Georgios Seitidis (G)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Sofia Tsokani (S)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Katerina-Maria Kontouli (KM)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Christos Christogiannis (C)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Dimitris Mavridis (D)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Gimon de Graaf (G)

Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3062 PA Rotterdam, The Netherlands.

Oliver Groene (O)

OptiMedis, 20095 Hamburg, Germany.

Maria G Grammatikopoulou (MG)

Immunonutrition and Clinical Nutrition Unit, Department of Rheumatology and Clinical Immunology, Medical School, University of Thessaly, Biopolis Campus, 43100 Larissa, Greece.

Francisco Camalleres-Guillem (F)

Spanish Society of Family Medicine, Infanta Mercedes Primary Care Centre, 28020 Madrid, Spain.

Lilisbeth Perestelo-Perez (L)

Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 38109 Tenerife, Spain.

Helen McGloin (H)

School of Nursing, Health Science and Disability Studies, ATU St Angelas, F91 C643 Sligo, Ireland.

Kirsty Winkley (K)

Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, London SE1 8WA, UK.

Beate Sigrid Mueller (BS)

Institute of General Practice, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50923 Cologne, Germany.

Zuleika Saz-Parkinson (Z)

European Research Executive Agency, 1000 Brussels, Belgium.

Rosa Corcoy (R)

CIBER Bioengineering, Biomaterials and Nanotechnology, Instituto de Salud Carlos III, 28220 Madrid, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.

Pablo Alonso-Coello (P)

Iberoamerican Cochrane Centre, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.

Classifications MeSH